Beyond ‘Baby Blues’: IOL Program Identifies, Treats Perinatal Depression

Peripartum Depression
Print icon

Pregnancy should be a time of joy, but for women with mental illness it can be a complex period with layers of anxiety, fear and guilt overshadowing the excitement and anticipation.

Up to 3 million women suffer from depression while pregnant and after giving birth, according to Art Guerra, APRN, director of the Peripartum and Adult Outpatient programs at the Institute of Living. Of those, he said 50 percent to 75 percent can be considered the more temporary “baby blues,” but up to 80 percent of women can experience perinatal mood and anxiety concerns that are considered moderate to severe.

“Many of these women are undiagnosed,” he said. “Others might be taken off their medications during pregnancy, which can be a problem.”

Untreated perinatal depression, for example, poses risks to the unborn baby, including:

  • Preterm delivery.
  • Lower birth weight.
  • Fetal distress.
  • Increased admission to a neonatal intensive care unit.
  • Increased incidence of cesarean section birth.
  • Death.

The pregnant woman is also at risk as a result. She can experience:

  • Poor prenatal care.
  • Substance use.
  • Inadequate pregnancy weight gain.
  • Preeclampsia, or high blood pressure.
  • Suicide.

“The mother-baby relationship can also suffer,” Guerra said. “There can be attachment issues, cognitive delays, behavioral problems and developmental delays in the child. Untreated depression in mothers has also been shown to lead to depressive, anxiety or disruptive disorders in about half of school-aged children.”

IOL’s Peripartum Program was started five years ago to fill a gap in the community and medically manage pregnant women and new mothers with moderate or severe mental health issues.

Besides depression, the program works with pregnant women and new mothers with anxiety and obsessive compulsive disorder and postpartum psychosis, which occurs in one or two out of every 1,000 births.

“Eighty percent of all new mothers report intrusive thoughts about deliberately or accidentally harming their babies,” Guerra said. “It impacts their ability to connect with their child and their quality of life.”

Even with the risks posed by mental illness, many women are reluctant to take medications during pregnancy for fear of harming their unborn baby. The Peripartum Program team works with women individually to outline the risk-benefit scenario of treatment.

“We help them understand the benefit of treatment,” Guerra said. “They can’t function as a mom if their mental health is severely impacted. Moms need decisional support.”

Dr. Karina Weiss, Peripartum Program psychiatrist and medical director of the Adult Resident Outpatient Clinic, said any treatment begins with behavioral therapy and may progress to medication if necessary. She said research indicates that the risks of taking SSRI medications such as Zoloft “are the same as not treating the depression at all.”

“Taking psychiatric medications pose risks to the mom and baby, including preterm birth, a risk of postnatal adaptation syndrome, possibly lower APGAR scores,” Dr. Weiss said. “But there are also risks to both mom and baby if the mom doesn’t take medication and leaves the depression or other mental health condition untreated. We will help mom weigh those risks and get the treatment she feels comfortable with.

“There is no ‘right’ answer and the literature is ambiguous, so it can be hard for parents and mental health providers to feel comfortable with their choice.”

For more information on the Mood Disorders Program at the Institute of Living, click here.  


What's New

Ketamine

What’s Next With New Ketamine Depression Drug? At IOL, a Study With Kids.

While the nation is clamoring for more information about the new treatment approved by the Food and Drug Administration for depression, Drs. Andrew Winokur and Mirela Loftus are quietly working on the next application. A nasal spray containing the active ingredient Esketamine — a chemical “relative” of the drug ketamine...


Turning Recovery into a Vocation

On the darkest days of his week-long hospitalization at Natchaug, Robert Belenchia talked to people. Diagnosed with general anxiety, attention deficit hyperactivity disorder (ADHD) and major depressive disorder, Belenchia had checked himself into the hospital after isolating himself for weeks in his Norwich apartment. Many of the people around him...

Opioids illustration

Suboxone Therapy Added to Institute of Living’s Professionals Program

A grim lesson of the opioid epidemic is that addiction can happen to anyone, including working people. The Professionals Addiction Recovery Program at the Institute of Living helps those in the workforce successfully address addiction issues. An intensive outpatient group therapy program designed to facilitate recovery efforts, the Professionals Program...

The Science of Love

Teledildonics? Could Your Next True-Love Sexual Partner Be Non-Human?

Questions about men’s health, including sexual function? Click here to download your free informational guide.  With human brains wired to connect, the digital age has only expanded the ability to make liaisons of all kinds, from romantic to robotic. Robotic? Indeed, the science of love, lust and intimacy has expanded...

Lego Forma

The Latest in Adult Relaxation: Lego Forma?

Coloring books to help adults destress are so 2018. Lego wants to replace your crayons, colored pencils and adult coloring books as a means of relaxation. Meet Lego Forma, a set of the plastic bricks aimed at an adult market. Sounds great, right? But it has people asking if this...


For Adolescents, Hope After Heroin

Adolescents can – and do – get into trouble with addictions to opioids. Medication-assisted treatment is now available locally for this age-group, according to Patricia Rehmer, president of the Hartford HealthCare Behavioral Health Network. Q: Tell us about the local recovery program that the Hartford HealthCare Behavioral Health Network provides...